EAST BRUNSWICK, N.J., May 2, 2011 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that it has granted time-based and performance-based options to purchase shares of common stock to Richard Crowley, the Company's newly appointed Executive Vice President of Biopharmaceutical Operations. The grants were made pursuant to the NASDAQ inducement grant exception as components of Mr. Crowley's employment compensation. The inducement grants were approved by the Company's Board of Directors on March 22, 2011 and are being made as an inducement material to Mr. Crowley's acceptance of employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4). Savient previously announced that Mr. Crowley has been appointed Executive Vice President of Biopharmaceutical Operations effective April 30, 2011.
The performance-based stock option is for the purchase of 50,000 shares of the Company's common stock with an exercise price equal to the closing price of the Company's common stock on April 29, 2011. The option has a ten-year term and will vest and become exercisable upon the satisfaction of the performance conditions agreed upon by Mr. Crowley and the Company's Board of Directors. In the event of the termination of Mr. Crowley's employment by the Company without "cause" (as such term is defined in the employment agreement between the Company and Mr. Crowley) or by Mr. Crowley for "good reason" (as such term is defined in the employment agreement), the performance-based stock option will immediately terminate and cease to be exercisable; provided, however, that such stock option will accelerate and become fully vested if, on or after the date of the announcement of a transaction which leads to a "change of control" (as such term is defined in the employment agreement) of the Company and up to 12 months following the date of the change in control, Mr. Crowley is terminated without cause or terminates his employment for good reason. In the event that any performance condition is not met by the specified date for achieving such performance condition (if any), the portion of such stock option subject to such performance condition will immediately terminate and cease to be exercisable.
The time-based stock option is for the purchase of 50,000 shares of the Company's common stock with an exercise price equal to the closing price of the Company's common stock on April 29, 2011. The option has a ten-year term and will vest and become exercisable as to 12,500 shares on April 29, 2012, and as to an additional 3,125 shares at the end of each successive three-month period thereafter until April 29, 2015. In the event of the termination of Mr. Crowley's employment by the Company without cause or by Mr. Crowley for good reason, the time-based stock option will immediately accelerate and become fully vested.
Savient is providing this information in accordance with NASDAQ Listing Rule 5635(c)(4).
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV